1,273 research outputs found

    Estimating Tail-Latency of Latency-Sensitive Workloads

    Get PDF
    Mange av arbeidsoppgavene som behandles i dagens datasentre er følsomme for forsinkelse, og krever at brukere har en tilfredsstillende opplevelse, noe som gjør energibesparing til en utfordring, som følge av strenge krav til forsinkelse. Oppgaveplanleggere er avgjørende for å redusere energiforbruket samtidig som disse kravene møtes. Denne masteroppgaven introduserer Heimdall, en løsning basert på enkle maskinlæringsmodeller (random forest og support vector machine) for å forstå korrelasjonen mellom kjerner, dynamisk spennings -og frekvensskalering (DVFS), arbeidsbelastning og forsinkelse. Våre eksperiment er gjennomført på et Nvidia Jetson TX1 brett, med resultater som viser at Heimdall reduserer energiforbruket med henholdsvis 2% og 16% i forhold til eksisterende oppgavebehandlere som Hipster og Heracles, og møter kravene for forsinkelse henholdsvis 11.2% og 6.1% oftere

    FUS is sequestered in nuclear aggregates in ALS patient fibroblasts

    Get PDF
    Mutations in the RNA-binding protein FUS have been shown to cause the neurodegenerative disease amyotrophic lateral sclerosis (ALS). We investigate whether mutant FUS protein in ALS patient–derived fibroblasts affects normal FUS functions in the nucleus. We investigated fibroblasts from two ALS patients possessing different FUS mutations and a normal control. Fibroblasts from these patients have their nuclear FUS protein trapped in SDS-resistant aggregates. Genome-wide analysis reveals an inappropriate accumulation of Ser-2 phosphorylation on RNA polymerase II (RNA Pol II) near the transcription start sites of 625 genes for ALS patient cells and after small interfering RNA (siRNA) knockdown of FUS in normal fibroblasts. Furthermore, both the presence of mutant FUS protein and siRNA knockdown of wild-type FUS correlate with altered distribution of RNA Pol II within fibroblast nuclei. A loss of FUS function in orchestrating Ser-2 phosphorylation of the CTD of RNA Pol II is detectable in ALS patient–derived fibroblasts expressing mutant FUS protein, even when the FUS protein remains largely nuclear. A likely explanation for this loss of function is the aggregation of FUS protein in nuclei. Thus our results suggest a specific mechanism by which mutant FUS can have biological consequences other than by the formation of cytoplasmic aggregates

    The Fama-French five-factor asset pricing model: A replication across the globe

    Get PDF
    Til tross for den kraftige empiriske ytelsen til fem-faktor-modellen til Fama og French (2015), er litteraturen om moderne kapitalverdimodeller (verdsetting av finansielle aktiva) sterkt påvirket av funn i det amerikanske aksjemarkedet. Denne oppgaven utvider dagens litteratur og søker å evaluere om fem-faktor-modellen rettet mot å fange størrelse, verdi, lønnsomhet og investeringsmønster i gjennomsnittlig aksjeavkastning er replikerbar over hele kloden. Denne oppgaven undersøker spesielt den empiriske ytelsen til fem-faktor-modellen og ulike varianter av den i USA, Nord-Amerika, Asia-Stillehavet (utenom Japan), Japan, Europa og fremvoksende markeder. Fem-faktor-modellen overgår konsekvent tre-faktor-modellen i USA, Nord-Amerika, Asia-Stillehavet (utenom Japan), Europa og fremvoksende markeder. I Japan tilføyer ikke fem-faktor-modellen en forbedring over tre-faktor-modellen. Resultatene indikerer at fem-faktor-modellen presterer bra, men at den ikke kan bli replikert over hele verden, og forskjellige markeder må ta hensyn til forskjellige sett med faktorer. Praktiske anvendelser av fem-faktor-modellen, som beregning av avkastningskrav til egenkapitalen og porteføljens ytelse kan være best uført på landsspesifikk basis.Despite the powerful empirical performance of the five-factor model of Fama and French (2015), the literature on modern asset pricing is heavily influenced by findings in the US stock market. This thesis extends the current literature and seeks to evaluate whether the five-factor model directed at capturing the size, value, profitability, and investment patterns in average stock returns is replicable across the globe. In particular, this paper empirically investigates the performance of the five-factor model and subset of its factors in the US, North America, Asia Pacific (excluding Japan), Japan, Europe, and Emerging Markets. The five-factor model consistently outperforms the three-factor model in the US, North America, Asia Pacific (excluding Japan), Europe, and Emerging Markets. In Japan, the five-factor model does not offer an improvement over the three-factor model. Results indicates that the five-factor model performs well, but does not replicate across the world, and different markets need to account for different sets of factors. Practical applications of the five-factor model, such as cost of equity capital calculations and performance evaluations, may be best performed on a country-specific basis

    Dysregulated protocadherin-pathway activity as an intrinsic defect in induced pluripotent stem cell-derived cortical interneurons from subjects with schizophrenia.

    Get PDF
    We generated cortical interneurons (cINs) from induced pluripotent stem cells derived from 14 healthy controls and 14 subjects with schizophrenia. Both healthy control cINs and schizophrenia cINs were authentic, fired spontaneously, received functional excitatory inputs from host neurons, and induced GABA-mediated inhibition in host neurons in vivo. However, schizophrenia cINs had dysregulated expression of protocadherin genes, which lie within documented schizophrenia loci. Mice lacking protocadherin-α showed defective arborization and synaptic density of prefrontal cortex cINs and behavioral abnormalities. Schizophrenia cINs similarly showed defects in synaptic density and arborization that were reversed by inhibitors of protein kinase C, a downstream kinase in the protocadherin pathway. These findings reveal an intrinsic abnormality in schizophrenia cINs in the absence of any circuit-driven pathology. They also demonstrate the utility of homogenous and functional populations of a relevant neuronal subtype for probing pathogenesis mechanisms during development

    Reprogramming of postnatal neurons into induced pluripotent stem cells by defined factors

    Get PDF
    Pluripotent cells can be derived from different types of somatic cells by nuclear reprogramming through the ectopic expression of four transcription factors, Oct3/4, Sox2, Klf4, and c-Myc. However, it is unclear whether postmitotic neurons are susceptible to direct reprogramming. Here, we show that postnatal cortical neurons, the vast majority of which are postmitotic, are amenable to epigenetic reprogramming. However, ectopic expression of the four canonical reprogramming factors is not sufficient to reprogram postnatal neurons. Efficient reprogramming was only achieved after forced cell proliferation by p53 suppression. Additionally, overexpression of repressor element-1 silencing transcription, a suppressor of neuronal gene activity, increased reprogramming efficiencies in combination with the reprogramming factors. Our findings indicate that terminally differentiated postnatal neurons are able to acquire the pluripotent state by direct epigenetic reprogramming, and this process is made more efficient through the suppression of lineage specific gene expression. STEM CELLS 2011;29:992–1000National Institutes of Health (U.S.) (Grant NIH HD045022)National Institutes of Health (U.S.) (Grant 5R37CA084198)Howard Hughes Medical Institut

    What\u27s Next?: Eco Materialism & Contemporary Art by Linda Weintraub

    Get PDF
    Review of Linda Weintraub\u27s What\u27s Next?: Eco Materialism & Contemporary Ar

    Cannabinoid CB1 Receptor: Role in Primate Prefrontal Circuitry and Schizophrenia

    Get PDF
    Schizophrenia is a complex and devastating psychiatric disorder that creates a substantial emotional and economic burden on individuals with the illness, their families, and society. Understanding the causes and identifying the molecular alterations in the brain that underlie the pathophysiology of core clinical features of schizophrenia are central to the development of new therapeutic interventions. In particular, schizophrenia is characterized by impairments in working memory, which are thought to result from a deficit in GABA neurotransmission in the dorsolateral prefrontal cortex (DLPFC). Interestingly, exposure to cannabis has been associated with an increased risk for developing schizophrenia and cannabis use is associated with DLPFC-related working memory impairments similar to those observed in schizophrenia. The effects of cannabis are mediated by the brain cannabinoid 1 (CB1) receptor, which in the rodent, is heavily localized to certain inhibitory axon terminals and, when activated, inhibits GABA release. Here, we have investigated the anatomical distribution of the CB1 receptor in the primate brain and characterized the cellular localization and synaptic targets of the CB1 receptor in the primate DLPFC. In addition, we explored the potential relationship between CB1 receptor signaling and altered GABA neurotransmission in schizophrenia by evaluating CB1 receptor mRNA and protein expression in the DLPFC of subjects with schizophrenia. We found that CB1 receptors are highly expressed in the primate DLPFC and that CB1 receptors are localized in the terminals of the subtype of perisomatic-targeting GABA interneurons that contain the neuropeptide cholecystokinin (CCK). We found that CB1 mRNA and protein are reduced in schizophrenia, which may represent a compensatory mechanism to increase GABA transmission from perisomatic-targeting CCK neurons with impaired GABA synthesis. We conclude that reductions in the expression of the CB1 receptor mRNA and protein in CCK neurons represent a novel neuropathological entity in the DLPFC of individuals with schizophrenia. These findings suggest a novel drug target for the treatment of cognitive dysfunction in schizophrenia
    corecore